Skip to main content
Astena Holdings Co., Ltd. logo

Astena Holdings Co., Ltd. — Investor Relations & Filings

Ticker · 8095 ISIN · JP3150000002 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2024-02-28 Annual Report
Country JP Japan
Listing T 8095

About Astena Holdings Co., Ltd.

https://www.astena-hd.com/en.html

Astena Holdings Co., Ltd. is a holding company managing a group of businesses across five primary segments: Fine Chemicals, Health & Beauty Care (HBC), Food, Medical, and Industrial Chemicals. The company is engaged in the development, manufacturing, supply, and wholesale of a diverse product portfolio. Its offerings include pharmaceuticals, over-the-counter (OTC) and veterinary drugs, medical equipment, cosmetic ingredients, and functional food ingredients. The group was established in 2021 following the transition of its predecessor, Iwaki & Co Ltd., to a holding company structure.

Recent filings

Filing Released Lang Actions
有価証券報告書－第84期(2022/12/01－2023/11/30)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains a cover page with the company name (Astena Holdings Co., Ltd.), the fiscal period (84th term, Dec 1, 2022 to Nov 30, 2023), and references to the Financial Instruments and Exchange Act. The presence of extensive XBRL-like metadata tags and financial reporting structure confirms it is the full annual financial filing. FY 2023
2024-02-28 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document text contains the Japanese phrase "訂正有価証券報告書（通常方式）" which translates to "Amended Securities Report (Normal Method)". It explicitly mentions the basis article of the Financial Instruments and Exchange Act ("金融商品取引法第24条の４の２第４項") and is submitted to the Kanto Local Finance Bureau Director ("関東財務局長"). A Securities Report (Yuka Shoken Hokokusho) in Japanese regulatory context is equivalent to the US SEC's Form 10-K (Annual Report) or Form 10-Q (Interim Report). Since this document is an *amendment* to a report covering a specific fiscal period (83rd period: Dec 1, 2021, to Nov 30, 2022), and it confirms the appropriateness of the contents of the original Securities Report, it is fundamentally related to the annual reporting cycle. Given the options, the closest equivalent for a comprehensive annual filing like a Securities Report is '10-K'. Although it is an amendment, the core document type being referenced and corrected is the annual filing. FY 2022
2024-01-25 Japanese
訂正有価証券報告書－第83期(2021/12/01－2022/11/30)
Annual Report Classification · 1% confidence The document is identified as a '訂正有価証券報告書' (Amended Securities Report) in Japanese, which corresponds to the Japanese equivalent of an Annual Report (10-K). It includes a cover page detailing the fiscal year (第83期), the company name (Astena Holdings Co., Ltd.), and references to XBRL data and financial statements. Although it is an amendment, it functions as the official annual financial filing. FY 2022
2024-01-25 Japanese
臨時報告書
Regulatory Filings Classification · 1% confidence The document is explicitly titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau Director on December 4, 2023. The filing reason states that the company resolved to transfer fixed assets (a property sale) in a board meeting on November 27, 2023, which constitutes an event significantly impacting the financial condition, results of operations, and cash flows. This type of disclosure in Japan, triggered by material events outside of regular reporting cycles, corresponds to a timely disclosure filing. Given the options, this is a general regulatory disclosure that doesn't fit the specific categories like 10-K (Annual Report), ER (Earnings Release), or IR (Interim Report). In the context of Japanese filings, this is best categorized as a general Regulatory Filing (RNS) or potentially a specific type of disclosure that falls under the broad 'Regulatory Filings' umbrella when a more precise match is unavailable. Since it is a mandatory, material disclosure outside of standard periodic reports, RNS (Regulatory Filings) is the most appropriate general classification for miscellaneous regulatory announcements.
2023-12-04 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act of Japan. This is a mandatory regulatory filing that accompanies a Quarterly Report (Shihanki Hokokusho) to confirm the accuracy of the report's contents. Since it is a specific regulatory filing required by law and does not fit into the categories of the report itself or a simple announcement, it is classified as a Regulatory Filing (RNS).
2023-10-13 Japanese
四半期報告書－第84期第3四半期(2023/06/01－2023/08/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) for Astena Holdings Co., Ltd., covering the third quarter of the 84th fiscal period (June 1, 2023, to August 31, 2023). It contains detailed financial statements, management analysis, and audit review information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-10-13 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.